The latest treatment advances for acute myelogenous leukemia.

摘要: The research into pathogenesis and mechanisms behind AML is advancing rapidly, but in general, translation global application for the majority of patients wanting. As more becomes known about cytogenetic molecular characteristics leukemia cells pathways leukemogenesis are further elucidated, it hoped that future therapies will be directed specifically toward least toxic method to eradicate clonal malignant cells. HLA-haploidentical alloBMT using KIR mismatch may dramatically improve survival many patients.